Breaks Categories: News

WednesdayJan 06, 2021 10:45 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in H.C. Wainwright BioConnect Virtual Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that it will participate in the virtual H.C. Wainwright BioConnect Conference taking place on Jan. 11-14, 2021. According to the update, AzurRx BioPharma president and CEO James Sapirstein will take part in virtual one-on-one meetings with registered investors and pharmaceutical companies. Sapirstein will be available to provide an overview of the company’s business and clinical development programs, as well as discuss anticipated 2021 milestones. Interested parties should visit https://nnw.fm/g3gtI to register for the event. To view the full press release, visit https://nnw.fm/oVHIy…

Continue Reading

WednesdayJan 06, 2021 10:05 am

NetworkNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) Appoints Auto Racing Entrepreneur to the PowerTap Advisory Board

Clean Power (CSE: MOVE) (OTC: MOTNF) (FWB: 2K6A) today announced the appointment of George Steinbrenner IV to the advisory board of PowerTap Hydrogen Fueling Corp. Clean Power, on Oct. 28, 2020, announced its investment in PowerTap as part of its strategy in the hydrogen sector. Steinbrenner is the youngest team owner within the NTT INDYCAR Series. His own embrace of practicing sustainability, reinforced by leadership and examples within his family and related businesses, adds to a commitment of following the lead of INDYCAR in its announced planned move to implement single-source hybrid systems beginning in 2023. "We are pleased that…

Continue Reading

WednesdayJan 06, 2021 9:31 am

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Upcoming H.C. Wainwright Bioconnect Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, on Tuesday announced that it will present at the H.C. Wainwright Bioconnect 2021 Conference. According to the update, the presentation will be available on-demand throughout the event from Jan. 11-14, 2021, starting at 6:00 a.m. ET. In addition, a webcast of the presentation will be available via the IR section of the company’s website and will be archived and accessible for at least 90 days. To view…

Continue Reading

WednesdayJan 06, 2021 8:30 am

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Launches Proprietary Technology for Obstructive Sleep Apnea Treatment

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea, announced its commercial launch of AireO2(TM). AireO2 is a new patient-management software technology designed to assist health-care providers to diagnose, treat and monitor patients with obstructive sleep apnea (“OSA”) and its related conditions. With an estimated 1 billion people suffering from OSA around the world, it is the most predominant diseases, and can cause life-threatening high blood pressure, heart failure, stroke and other health problems. and life-threatening diseases. “We believe that Vivos’ sleep-specific AireO2 patient…

Continue Reading

TuesdayJan 05, 2021 12:21 pm

NetworkNewsBreaks – Ideanomics (NASDAQ: IDEX) Announces Agreement to Acquire Utah-Based Wireless Charging Provider WAVE

Ideanomics (NASDAQ: IDEX) has signed a definitive agreement to acquire privately held Wireless Advanced Vehicle Electrification Inc. ("WAVE"). The agreement outlines plans for a 100% acquisition in exchange for cash and stock considerations; full terms of the agreement are contained in the company’s 8-K filing. Based in Salt Lake City, WAVE provides inductive, or wireless, charging solutions for medium and heavy-duty electric vehicles (“EVs”). The fully automated, hands-free WAVE system is embedded in roadways and charges vehicles during scheduled stops; it provides a solution to battery-range limitations, enabling fleets to reach driving ranges comparable to those of internal combustion engines (“ICE”) vehicles. The…

Continue Reading

TuesdayJan 05, 2021 11:50 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Expands Category Verticals to Launch Plant-Based Baby Products

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced that its U.S. ecommerce platform www.PlantX.com will begin featuring baby formula products from Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL). The addition of plant-based baby formula allows PlantX to further expand its category verticals. Else Nutrition’s baby formula will be the first product available to order in the new baby products section of PlantX Life’s U.S. ecommerce platform. “We are thrilled to be listed on the PlantX platform. Joining this innovative online platform solely dedicated to plant-based companies aligns perfectly with our mission to bring clean label…

Continue Reading

TuesdayJan 05, 2021 11:36 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Announces Appointment of Executive Vice President of Finance and Strategy

PowerBand Solutions (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), an innovative automotive fintech leader providing digital and virtual platform solutions, today announced the appointment of Steve Waller as executive vice president of Finance and Strategy, North American Operations. According to the update, Waller will also serve as a director for both PowerBand U.S. and its majority-owned financial subsidiary, MUSA Holdings. Waller brings senior-level executive experience and expertise in the automotive public and private retail sector and the banking and finance industry. "We are extremely pleased that Steve is joining the PowerBand team. His contributions will maximize our ability to capitalize on…

Continue Reading

TuesdayJan 05, 2021 11:30 am

NetworkNewsBreaks – Predictive Oncology (NASDAQ: POAI) Engages Investor Relations Firm

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that it has hired an investor relations firm. POAI has chosen Landon Capital to provide investor relations services; the agreement was effective Dec. 30, 2020. The announcement noted that anticipated services would include introductions to investors, financial and industry analysts, registered brokers and financial writers. Those introductions would be made with the intent to provide interested individuals and groups with information about POAI’s business strategy, developments and accomplishments. The announcement also noted that Landon Capital would assist POAI in the…

Continue Reading

TuesdayJan 05, 2021 11:04 am

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Successful Fuel4Thought(TM) Study, Substantial Opportunity for Proven, Market-Disruptive Remedy

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM) (“UBN”) has successfully completed a pilot study for its proprietary Fuel4Thought(TM) (F4T(TM)) formulation to help with migraines. It is an exciting development for Grey Cloak as it looks to embolden its revenue opportunities, providing substantial potential reach for a proven, market-disruptive remedy. According to GRCK president Duke Pitts, nearly 40 million people suffer from some form of migraines in the United States…

Continue Reading

TuesdayJan 05, 2021 10:39 am

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters into Agreement with Fortune 500 Subsidiary to Provide Digital Therapeutics Solution

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has been selected by a subsidiary of a U.S.-based Fortune 500 technology and engineering company to provide its digital therapeutics solution to eligible employees. DarioHealth’s partnership with Vitality Group made this agreement possible, which is DarioHealth’s first client in the self-insured employer market. One of the largest wellness companies in the world, Vitality Group blends industry-leading smart tech, data, incentives and behavioral science to inspire healthy changes in individuals and their organizations; an estimated 20 million people in 26 markets engage in the Vitality program. Under the announced agreement, members…

Continue Reading